Related Experiment Video
Updated: Aug 20, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole
Judith A Guzman-Cottrill1, Xiaotian Zheng, Ellen G Chadwick
1Division of Infectious Disease, Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Children's Memorial Hospital, Chicago, IL, USA.
Abstract:
Fungal infections caused by Fusarium in the immunocompromised host are highly resistant to all antifungal agents. Fusarium endocarditis is a rare and usually fatal disease. We report an immunocompromised child who survived Fusarium solani endocarditis despite the in vitro resistance of the organism to all available antifungal agents.
Insights
This study details a rare case of Fusarium endocarditis in an immunocompromised child. Despite the fungus being resistant to antifungals, the child survived this typically fatal infection.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Medicine
Background:
- Fusarium species are emerging opportunistic fungal pathogens.
- Infection in immunocompromised hosts often leads to severe, invasive disease.
- Fusarium endocarditis is exceptionally rare and carries a high mortality rate.
Observation:
- A case of Fusarium solani endocarditis in an immunocompromised child is presented.
- The causative organism demonstrated in vitro resistance to all tested antifungal agents.
- Despite the resistance, a successful clinical outcome was achieved.
Findings:
- Successful management of a life-threatening Fusarium endocarditis infection was achieved.
- This case highlights potential therapeutic strategies beyond standard antifungal therapy.
- The study underscores the importance of considering novel treatment approaches for resistant fungal infections.
Implications:
- This case may inform treatment strategies for rare and resistant fungal infections.
- Further research into alternative therapies for Fusarium infections is warranted.
- Improved outcomes are possible even in the face of antifungal resistance in immunocompromised patients.
Related Concept Videos
Antifungal Agents
Endocarditis III: Medical Management
Cryptococcal Meningitis
Candidiasis
Endocarditis IV: Nursing Management
Endocarditis I: Introduction